bioRxivCancer BiologyPreprint
Evolutionary conserved reciprocal senescence and tumor suppressor signals limit lifetime cancer
Liqiong Liu, Stephani A. Davis, Shamila Yusuff, Ann StrangeiD, Yonghua ZhuangiD, Prasanna Kumar VaddiiD, Kathleen Flaherty, Kelly JaraiD, Joseph KrameriD, Christine Archer, Schuyler LeeiD, Bifeng GaoiD, Adrie van BokhoveniD, Wei WangiD, Sharon R. PineiD, Tetsuya NakamuraiD, Hatem E. SabaawyiD
Abstract
Cellular senescence features a durable exit from the cell cycle triggered by stress or carcinogens. The INK4 locus is inactivated in various cancers, yet in senescence, p16Ink4a is activated. Whether senescence is tumor-suppressing or -promoting remains a conundrum. We discovered an evolutionally-conserved Vertebrata INK4-homolog. This ink4ab triggers senescence upon oxidative- and/or carcinogenic-stress. Adult Ink4ab-deficient animals failed to activate senescence and developed spontaneous cancers. Combined Ink4ab and Tp53 deficiency revealed a reciprocal senescence and apoptosis regulation, controlling tumorigenesis, including retinoblastoma. INK4-hematopoietic-deficient mice exhibited p19Arf-dependent enhanced senescence-like phenotypes, uncontrolled cell proliferation, defective stem cell differentiation, and splenomegaly, with single-splenocytes spatially-enriched in senescence-associated secretory profiles. Our studies reveal the evolutionary origin of paradigms co-regulating senescence and tumor suppression and offer strategies to exploit these reciprocal pathways for cancer prevention and therapy.
- organism: mouse
- assay: spatial transcriptomics
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: genetic perturbation / CRISPR
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pharmacological CDK4/6 inhibition unravels a p53-induced secretory phenotype in senescent cells
B. Wang, S. Brandenburg, … M. Demaria·bioRxiv·Jun 5, 2020
- Oncogene inactivation-induced senescence facilitates tumor relapse
Philipp Schmitt, Katrin Hönig, … Thomas Blankenstein·Nature CommunicationsPeer-reviewed·Jul 15, 2026
- Induction of Senescence During Postpartum Mammary Gland Involution supports tissue remodeling and promotes postpartum tumorigenesis
Aurélie Chiche, Lamia Djoual, … Han Li·Nature AgingPeer-reviewed·Feb 18, 2026
- Early growth response 2 (EGR2) is a novel regulator of the senescence program
E. J. Tyler, A. Gutierrez Del Arroyo, … C. L. Bishop·bioRxiv·Sep 30, 2020
- CDK4/6 inhibition induces a DNA damage-independent senescence-associated secretory phenotype driven by delayed activation of NF-κB
Joanna Lan-Hing Yeung, Justin Rendleman, … Viviana I. Risca·bioRxiv·Aug 25, 2025
- AKT1 is Required for a Complete Palbociclib-induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma
A. L. Bayer, J. Pietruska, … P. W. Hinds·bioRxiv·Dec 2, 2021